Xudong Zhang

2PUBLICATIONS
5CO-AUTHORS
Haematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 28, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma.

|Jan 04, 2026
A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

Wanyue Zhao, Ling Li, Xiaorui Fu

Pageof 1

Frequent Collaborators

2 joint publications

Qingjiang Chen

2 joint publications

Mingzhi Zhang

1 joint publications

Wanyue Zhao

1 joint publications

Shanshan Ma